Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of InterMedical Care and Lab Hospital PCL was 213.40% per year. The lowest was 129.50% per year. And the median was 171.45% per year.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
InterMedical Care and Lab Hospital PCL 3-Year EPS without NRI Growth Rate Related Terms
BKK:IMH-R vs HCA, THC, EHC: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate falls into.
InterMedical Care and Lab Hospital PCL 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 0.00% mean?
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) has a 3-Year EPS without NRI Growth Rate of 0.00% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for InterMedical Care and Lab Hospital PCL and its competitors. Over the past decade, InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate has ranged from 129.50 to 213.40. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 502 companies in the Healthcare Providers & Services industry.
Is InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate too high?
InterMedical Care and Lab Hospital PCL's current 3-Year EPS without NRI Growth Rate is 0.00%. Over the past 10 years, this metric has ranged from a low of 129.50 to a high of 213.40. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 502 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 502 companies for 3-Year EPS without NRI Growth Rate. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 10.70. Historically, InterMedical Care and Lab Hospital PCL's own 3-Year EPS without NRI Growth Rate has ranged from 129.50 to 213.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 10.70, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current 3-Year EPS without NRI Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH-R) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.85, compared to a current price of ฿3.62 — trading 38.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 0.00%. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH-R), the current 3-Year EPS without NRI Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH-R:
3-Year EPS without NRI Growth Rate: 0.00%
GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score
Get the complete analysis for BKK:IMH-R
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH-R has been successfully added to your 
